We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Oral Presentations.
- Abstract
To date 3 patients could be weaned from LVAD therapy, 1 patient was successfully heart transplanted and 15 patients are listed or in the process for listing for heart transplantation. We performed a 1:1 matched-pairs analysis of 121 patients with ERLT and whole organ LT each, using the matching criteria recipient and donor age and recipient MELD score. Hospitalized patients (regular ward and ICU) showed a dramatically shorter 3-month, 1- and 3-year survival compared to patients from home (78.7% vs. 94.4%; 66.3% vs. 87.3%; 61.7% vs. 81.7%; all p < 0.001) while no significant difference was detected between ICU and regular ward patients (3-year survival: 61.5% vs. 62.3%; p = 0.598) After Propensity Score Matching survival in the hospitalized groups remained significantly worse compared to non-hospitalized patients (82.1% vs. 91.0%; 69.2% vs. 83.3%; 60.3% vs. 82.1%, p = 0.019, p = 0.003, p < 0.001). B Results: b Overall, antigen-allospecific antibodies against various NKC- and LRC-encoded receptors such as NKG2C, KIR2DL2/DS2, KIR2DS1/DL1 and LILRB3 were found in 20% of Kidney recipient patents ( I n i = 15), 19% of liver recipient patients ( I n i = 42) and 17% of lung recipient patients ( I n i = 41). Patients with additional kidney transplantation were excluded from analysis leading to a cohort of 211 patients for the investigation of independent influences of ATG on patient survival, graft survival and cancer-free survival using multivariable Cox regression analysis.
- Subjects
INTESTINE transplantation; ISCHEMIC preconditioning; GRAFT versus host disease; TRANSPLANTATION of organs, tissues, etc.; LIVER transplantation; HEART transplantation; KIDNEY transplantation
- Publication
Transplant International, 2019, Vol 32, p8
- ISSN
0934-0874
- Publication type
Article
- DOI
10.1111/tri.13499